Reports
Reports
Sale
The Australia and New Zealand diagnostic imaging services market size is anticipated to grow at a CAGR of 6.34% during the forecast period of 2024-2032, driven by the increasing incidence of oncological, cardiovascular, and musculoskeletal disorders.
The growth of the market is being driven by the growing ageing population and increased prevalence of chronic diseases. This has led to an increase in healthcare expenditure and has significantly contributed to expanding diagnostic imaging services in the region. The growth of the Australia and New Zealand diagnostic imaging services market value is also driven by the growing burden of chronic diseases, like cardiovascular diseases and cancer, along with increased healthcare investments and technological advancements.
Continuous technological advancements in imaging technologies, coupled with a growing awareness among the population about the importance of early diagnosis, has further fueled the demand for diagnostic imaging services in Australia and New Zealand. In April 2021, Koninklijke Philips N.V. installed its most advanced digital diagnostic and interventional neurovascular imaging solutions at Westmead Hospital Australia, leading to the expansion of the diagnostic imaging services in the region.
Government initiatives aimed at improving healthcare infrastructure, reducing waiting times, and enhancing accessibility to healthcare services, have also been contributing to the rising Australia and New Zealand diagnostic imaging services market] share . Additionally, strategic collaborations among diagnostic imaging service providers, healthcare facilities, and technology companies, along with adopting telemedicine and teleradiology services, have positively impacted the market dynamics.
The regulatory support for maintaining high standards in diagnostic imaging services also ensures the reliability of diagnostic results, further fostering market growth. According to the Australian Institute of Health and Welfare, in Australia and New Zealand, chronic diseases together caused 85% of the total burden of disease, which is a similar figure to chronic diseases accounting for 90% of the burden due to deaths alone.
The Australia and New Zealand diagnostic imaging services market growth is being driven by advancements in medical technology and increasing healthcare awareness. This dynamic market is witnessing a rising demand for cutting-edge ultrasound devices, including portable and 3D/4D imaging systems. The regions’ healthcare infrastructure development, coupled with a growing elderly population, also contributes to the expanding market. Additionally, the emphasis on early disease detection and prenatal care fuels the adoption of ultrasound technology.
Increasing Disease Burden to Drive the Growth
The growing incidence of diseases, such as cancer and cardiovascular disorders, is aiding the rising demand for diagnostic imaging services, as early detection and accurate diagnosis are crucial for effective treatment. According to the Australian Prevention Partnership Centre statistics, in Australia, chronic diseases cause 9 out of every 10 preventable deaths 2 and account for 85% of years lost due to ill health or early death. This has facilitated the research and developmental activities and henceforth in the discovery of novel diagnostic imaging services in the market.
Rising Initiatives by the State Governments to Aid the Market
The state governments have formulated initiatives to improve healthcare infrastructure, enhance diagnostic capabilities, and ensure better accessibility to healthcare services playing a pivotal role in the Australia and New Zealand diagnostic imaging services market growth. Government investments in healthcare infrastructure projects and policies aimed at reducing waiting times for diagnostic procedures are notable in both countries. In May 2023, the Australian Government provided USD 8.3 million to improve training opportunities for specialist doctors in regional Australia through round two of the Flexible Approach to Training in Expanded Settings (FATES) program.
Rapid Technological Advancements to Benefit the Market
Continuous innovations in diagnostic imaging technologies, including MRI, CT, and ultrasound, are accelerating the market growth, as healthcare providers invest in advanced equipment to enhance diagnostic capabilities. The adoption of 3D mammography and the integration of artificial intelligence (AI) in diagnostic imaging is anticipated to boost the Australia and New Zealand diagnostic imaging services market size in the forthcoming years.
In June 2023, the Hospital for Special Surgery (HSS), the world's leading academic medical centre specialized in musculoskeletal health, and New Zealand-based medical device and technology company MARS Bioimaging Limited (MARS) collaborated for the MARS’s photon-counting spectral CT imaging technology. Through the HSS Innovation Institute, HSS and MARS will advance musculoskeletal imaging and diagnosis, including evaluation of specific aspects of the MARS 5x120 Extremity Scanner and potential co-development of new scanning technologies and systems.
Market Breakup by Modality
Market Breakup by Application
Market Breakup by End User
Market Breakup by Country
The diagnostic imaging market in Australia and New Zealand exhibits a moderate level of competitiveness, with prominent players. Key market leaders include Mindray Medical International Limited, Siemens Healthineers AG, GE Healthcare, Fujifilm Holdings Corporation, and Koninklijke Philips NV, among others.
In December 2023, Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proposed an acquisition offer to Volpara Health Technologies Ltd., a global leader in AI-enabled software for the early detection and prevention of cancer. This strategic move comes as a result of an exhaustive evaluation of potential avenues for growth and innovation by Lunit.
The key features of the Australia and New Zealand diagnostic imaging services market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Modality |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand Diagnostic Imaging Services Market Overview
3.1 Australia and New Zealand Diagnostic Imaging Services Market Historical Value (2017-2023)
3.2 Australia and New Zealand Diagnostic Imaging Services Market Forecast Value (2024-2032)
4 Australia and New Zealand Diagnostic Imaging Services Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Australia and New Zealand Diagnostic Imaging Services Market Segmentation
5.1 Australia and New Zealand Diagnostic Imaging Services Market by Modality
5.1.1 MRI
5.1.2 Computed Tomography
5.1.3 Ultrasound
5.1.4 X-ray
5.1.5 Nuclear Imaging
5.1.6 Fluoroscopy
5.1.7 Mammography
5.1.8 Other Modalities
5.2 Australia and New Zealand Diagnostic Imaging Services Market by Application
5.2.1 Market Overview
5.2.2 Cardiology
5.2.3 Oncology
5.2.4 Neurology
5.2.5 Orthopedics
5.2.6 Gastroenterology
5.2.7 Gynecology
5.2.8 Other Applications
5.3 Australia and New Zealand Diagnostic Imaging Services Market by End User
5.3.1 Market Overview
5.3.2 Hospitals
5.3.3 Diagnostic Centres
5.3.4 Others
5.4 Australia and New Zealand Diagnostic Imaging Services Market by Country
5.4.1 Market Overview
5.4.2 Australia
5.4.3 New Zealand
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Siemens Healthineers
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 GE Healthcare
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Philips Healthcare
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Fujifilm Holdings Corporation
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Hologic Inc.
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Hitachi Medical Corporation
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Shimadzu Corporation
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Carestream Health, Inc.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Canon Medical Systems Corporation
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Toshiba Medical Systems Corporation (now part of Canon Medical Systems)
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 Agfa-Gevaert Group
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Samsung Medison Co., Ltd.
11.12.1 Financial Analysis
11.12.2 Financial Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 Aurora Imaging Technology, Inc.
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Esaote S.p.A.
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 Mindray Medical International Limited
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Australia and New Zealand Diagnostic Imaging Services Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market is anticipated to grow at a CAGR of 6.34% during the forecast period of 2024-2032.
The market demand is driven by the increasing burden of chronic diseases such as cardiovascular diseases and cancer, coupled with the rising healthcare investment in the country and technological advancements.
The current market trend involves rising support from the government in the form of initiatives and investments in ultrasound devices.
It is commonly divided into MRI, computed tomography, ultrasound, X-ray, nuclear imaging, fluoroscopy, mammography, and other modalities.
Major applications are cardiology, oncology, neurology, orthopedics, gastroenterology, and gynaecology, among other applications.
Major end users include hospitals and diagnostic centres, among others.
The key players in the market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Hologic, Inc., Hitachi Medical Corporation, Shimadzu Corporation, Carestream Health, Inc., Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Agfa-Gevaert Group, Samsung Medison Co., Ltd., Aurora Imaging Technology, Inc., Esaote S.p.A., and Mindray Medical International Limited.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.